This study was published in Nature.

Researchers found that in mice, a molecule called N-0385 was effective in preventing and treating COVID infection when introduced 12 hours after exposure. A California company, EBVIA Therapeutics Inc. is now in the processing of raising funds to start human trials.

This study showed promising results, so we may just have a nasal spray in the mix for prevention and treatment in the future.